(Q80933886)

English

Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia

scientific article published on 01 October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

stem cell transplantation

1 reference

based on heuristic

inferred from title

myeloid leukemia

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

author name string

Cordonnier C

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Maury S

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Esperou H

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Pautas C

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Beaune J

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Rodet M

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Lagrange JL

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Rouard H

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Beaumont JL

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Bassompierre F

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Glückman E

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Kuentz M

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Durand-Zaleski I

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

36

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

649-654

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16044135%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705109

0 references

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased Transfusion Requirements in Patients Given Stem Cell Allografts Using a Non-myeloablative Conditioning Regimen: A Single Institution Experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

PREDICTING THE COSTS OF ALLOGENEIC SIBLING STEM-CELL TRANSPLANTATION: RESULTS FROM A PROSPECTIVE, MULTICENTER, FRENCH STUDY

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting costs of stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective cost evaluation related to allogeneic haemopoietic stem cell transplantation including pretransplant procedures, transplantation and 1 year follow-up procedures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

A detailed analysis of charges for hematopoietic stem cell transplantation at a children's hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705109

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80933886&oldid=2037690017"